🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 110 of 114

  1. neratinib

    PUMA BIOTECHNOLOGY, INC.

    HER2+ Metastatic Breast Cancer (MBC)

    phase 3 small molecule completed

    1 trial

  2. nexiguran ziclumeran

    Regeneron UK Limited

    Neuromuscular Disease

    phase 3 mab active

    1 trial

  3. nicotine transdermal system

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 3 small molecule completed

    2 trials

  4. nintedanib, Nintedanib, nintedanib

    Boehringer Ingelheim

    Childhood Interstitial Lung Disease

    phase 3 small molecule active

    1 trial

  5. nivolumab

    Bristol-Myers Squibb

    Breast Cancer

    phase 3 mab completed

    1 trial

  6. nomacopan (rVA576)

    Akari Therapeutics Plc

    Thrombotic Microangiopathies

    phase 3 small molecule terminated

    1 trial

  7. nomacopan (rVA576)

    Akari Therapeutics Plc

    Bullous Pemphigoid

    phase 3 small molecule terminated

    1 trial

  8. non-pegylated liposomal doxorubicin

    Teva Pharma GmbH

    Tubular Breast Cancer Stage II

    phase 3 small molecule completed

    1 trial

  9. nonacog beta pegol

    Novo Nordisk A/S

    Congenital Bleeding Disorder

    phase 3 small molecule completed

    1 trial

  10. normal saline solution for infusion, Ociperlimab, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Tislelizumab, Ociperlimab

    BeiGene

    Locally advanced, unresectable, or metastatic non small cell lung cancer

    phase 3 small molecule active

    1 trial

  11. novel stent

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Cancer

    phase 3 other active

    1 trial

  12. nutritional supplement

    Abbott Australasia Pty Ltd

    Children

    phase 3 other completed

    1 trial

  13. obinutuzumab

    Hoffmann-La Roche

    Lymphocytic Leukemia, Chronic

    phase 3 small molecule completed

    1 trial

  14. obrixtamig

    Boehringer Ingelheim

    Small Cell Lung Cancer (SCLC)

    phase 3 small molecule active

    1 trial

  15. ofloxacin

    ABEONA THERAPEUTICS INC.

    Diabetic Foot Ulcers

    phase 3 small molecule completed

    2 trials

  16. olmesartan alone or in combination with hydrochlorothiazide

    Pfizer

    Essential Hypertension

    phase 3 small molecule completed

    1 trial

  17. omega-3-acid ethyl esters 90 (TAK-085)

    Takeda

    Hypertriglyceridemia

    phase 3 small molecule completed

    2 trials

  18. one percent ultrasound power in CMICS

    Hospital Authority, Hong Kong

    Cataract

    phase 3 other active

    1 trial

  19. oral estradiol 1.0 mg

    TherapeuticsMD

    Menopause

    phase 3 small molecule completed

    1 trial

  20. oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab

    Takeda

    Colorectal Cancer

    phase 3 small molecule completed

    1 trial

  21. paclitaxel

    United Therapeutics Europe Ltd

    Germ Cell Tumor

    phase 3 small molecule active

    1 trial

  22. paclitaxel/anthracycline

    The First People's Hospital of Lianyungang

    Primary Breast Cancer

    phase 3 small molecule active

    1 trial

  23. pad-gauze with tranexamic acid (Hemostopan™)

    Sionna Therapeutics

    Bleeding

    phase 3 other active

    1 trial

  24. pagoclone

    Teva Pharma GmbH

    Stuttering

    phase 3 small molecule completed

    1 trial

  25. pantoprazole 20 mg (drug)

    Takeda

    Chronic Use of Acid Suppressive Medication

    phase 3 small molecule active

    1 trial

  26. paricalcitol

    Chinese University of Hong Kong

    IgA Nephropathy

    phase 3 small molecule terminated

    1 trial

  27. patients undergo cVATS segmentectomy

    The First People's Hospital of Lianyungang

    Non-small Cell Lung Cancer Stage I

    phase 3 other active

    1 trial

  28. patients were assigned to receive TNT or iTNT management

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  29. patisiran (ALN-TTR02)

    Alnylam Netherlands B.V.

    TTR-mediated Amyloidosis

    phase 3 small molecule completed

    1 trial

  30. pegaptanib sodium

    Pfizer

    Macular Degeneration

    phase 3 small molecule completed

    1 trial

  31. pegcyte

    Biotech Pharmaceutical Co.,

    Breast Cancer Female

    phase 3 small molecule completed

    1 trial

  32. pegfilgrastim

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 mab active

    1 trial

  33. peginesatide

    Takeda

    Chronic Renal Failure

    phase 3 small molecule completed

    4 trials

  34. peginterferon alfa-2a

    Hoffmann-La Roche

    Hepatitis C, Chronic

    phase 3 small molecule completed

    2 trials

  35. peginterferon alfa-2b (SCH 54031)

    Universal Integrated

    Hepatitis C, Chronic

    phase 3 mab completed

    1 trial

  36. pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Non-small Cell Lung Cancer

    phase 3 mab completed

    2 trials

  37. pembrolizumab/vibostolimab

    Merck KGaA, Darmstadt, Germany

    Carcinoma, Non-Small-Cell Lung

    phase 3 mab active

    1 trial

  38. pemetrexed

    Eli Lilly and Company

    Head and Neck Neoplasms

    phase 3 small molecule completed

    1 trial

  39. perampanel

    Eisai Co.,

    Epilepsy

    phase 3 small molecule completed

    2 trials

  40. phenytoin

    Ultragenyx UK Limited

    Post-Traumatic Seizure Disorder

    phase 3 small molecule completed

    1 trial

  41. piclidenoson

    Can-Fite BioPharma

    Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  42. pimavanserin tartrate

    Acadia Pharmaceuticals B.V.

    Parkinson's Disease Psychosis

    phase 3 small molecule completed

    1 trial

  43. pioglitazone

    Hoffmann-La Roche

    Diabetes Mellitus Type 2

    phase 3 small molecule completed

    1 trial

  44. pioglitazone

    Takeda

    Stroke

    phase 3 small molecule completed

    1 trial

  45. placebo

    Takeda

    Non-cancer Pain

    phase 3 small molecule terminated

    1 trial

  46. placebo

    Pfizer

    Schizophrenia

    phase 3 small molecule terminated

    1 trial

  47. placebo

    Boehringer Ingelheim

    Pulmonary Fibrosis

    phase 3 small molecule completed

    1 trial

  48. placebo

    Takeda

    Osteoporosis

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.